Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 05-2021 | 02-2021 | 11-2020 | 08-2020 | 05-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,657 | -24,275 | -43,242 | -23,328 | -4,811 |
| Depreciation Amortization | 3,430 | 1,607 | 2,453 | 1,666 | 1,036 |
| Accounts receivable | -2,537 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,119 | 899 | 1,234 | 602 | 1,745 |
| Other Working Capital | 17,101 | 28,021 | 36,408 | 40,299 | 29,668 |
| Other Operating Activity | 7,062 | 1,801 | 3,067 | 1,163 | -1,095 |
| Operating Cash Flow | $-23,482 | $8,053 | $-80 | $20,402 | $26,543 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,934 | -843 | -4,553 | -3,647 | -1,977 |
| Purchase Of Investment | -183,238 | -47,742 | -275,224 | -141,067 | -29,640 |
| Sale Of Investment | 126,675 | 46,198 | 25,373 | 14,873 | 9,857 |
| Investing Cash Flow | $-59,497 | $-2,387 | $-254,404 | $-129,841 | $-21,760 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 151,831 | 1,360 | 219,117 | 220,238 | 177 |
| Common Stock Repurchased | -1 | -1 | -7 | -2 | -1 |
| Other Financing Activity | 0 | 0 | 119,914 | 119,914 | 119,554 |
| Financing Cash Flow | $151,830 | $1,359 | $339,024 | $340,150 | $119,730 |
| Beginning Cash Position | 119,526 | 119,526 | 34,986 | 34,986 | 34,986 |
| End Cash Position | 188,377 | 126,551 | 119,526 | 265,697 | 159,499 |
| Net Cash Flow | $68,851 | $7,025 | $84,540 | $230,711 | $124,513 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,482 | 8,053 | -80 | 20,402 | 26,543 |
| Capital Expenditure | -2,934 | -843 | -4,553 | -3,647 | -1,977 |
| Free Cash Flow | -26,416 | 7,210 | -4,633 | 16,755 | 24,566 |